Searched for
CUREVAC
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- Stablecoin firm Circle triples after IPO priced above rangeCircle Internet Group witnessed a remarkable surge, with shares soaring up to 235% following its IPO. The stablecoin issuer and its shareho...
- European shares slip from record highs on hawkish Fed; CureVac sinksThe pan-European STOXX 600 index was down 0.3 per cent, snapping a nine-day gaining streak, after the Fed said it could begin raising inter...
- EU regulator does not expect approval for CureVac vaccine before AugustThe source said German health minister Jens Spahn had provided the update on the EMA's view on the timing of the review on Monday in a call...
- Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...
- Curevac says May approval for COVID-19 vaccine possible: Newspaper"We are already very advanced in Phase Three clinical trials and are expecting the data for the final approval package," spokesman Thorsten...
- CureVac says preliminary trials show COVID-19 vaccine effective against variantsHaas told EU lawmakers that the results of the preliminary trials on the vaccine's effects on variants would be published soon.
- Can we avoid another coronavirus pandemic?Trials have been on in Europe and Latin America since December, and the results could be out as early as next month. The good news is that,...
- Pan-European consortium seeks big pharma partner for COVID-19 shotA pan-European consortium developing a COVID-19 vaccine is in talks with big pharma to support the late-stage development of its shot and r...
- GSK, CureVac partnership eyes COVID-19 vaccine against multiple variantsGSK, which holds a stake in CureVac, will also support the production of up to 100 million doses of CureVac's first generation COVID-19 vac...
- Bayer aims to help CureVac with COVID-19 vaccine output, says CEOThough inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots i...
- COVID-19 vaccine contender CureVac links up with BayerCureVac, based in the German city of Tuebingen, said last month that it expects first results by the end of March from its phase 3 clinical...
- EU could pay over $10 billion for Pfizer, CureVac vaccinesThe European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfi...
- New global lab network will compare vaccines head-to-headIn a network spanning Europe, Asia and North America, the labs will centralise analysis of samples from trials of Covid-19 candidates “as t...
- EU talks with Pfizer, Sanofi, J&J on COVID-19 vaccines hit pricing, payment roadblocksThe bloc is in talks with at least six vaccine makers to acquire up front doses of potential shots against the novel coronavirus, officials...
- GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
- European Union in talks with Moderna, BioNtech, CureVac to secure Covid-19 vaccinesThe talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential C...
- Germany approves new powers to block foreign takeovers in healthcareThe regulation, approved by the cabinet, will allow the government to block takeovers of makers of vaccines, precursor chemicals, medicines...
- Germany hits back over US virus vaccine interest"Germany is not for sale," economy minister Peter Altmaier told broadcaster ARD, reacting to a front page report in Welt am Sonntag newspap...
- Germany tries to stop US from luring away firm seeking coronavirus vaccineOn its website, CureVac said CEO Daniel Menichella early this month met Trump, Vice President Mike Pence, members of the White House Corona...
Load More
